复星医药：关于控股子公司获药品注册申请受理的公告

Group 1 - The core point of the article is that Fosun Pharma announced the acceptance of its subsidiary's drug registration application for injection of Nedaplatin by the National Medical Products Administration [2] Group 2 - The announcement was made on the evening of August 12 [2] - The subsidiary involved is Gismed (Wuhan) Pharmaceutical Co., Ltd. [2] - The drug in question is Nedaplatin, which is used for injection [2]